Last reviewed · How we verify

NCT07247721: TENS vs PENS

Transcutaneous vs Percutaneous Electrical Stimulation of the Radial Nerve

Active, enrolled NA Last updated 27 February 2026
What this trial tests

NA trial testing Transcutaneous Electrical Nerve Stimulation (TENS) in Pain Modulation in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 January 2026
Primary endpoint
15 March 2026
15 April 2026

Quick facts

Lead sponsorUniversity of Castilla-La Mancha
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment120
Start date15 January 2026
Primary completion15 March 2026
Estimated completion15 April 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Castilla-La Mancha

Who can join

Adults 18 to 60, any sex, with Pain Modulation or Sensorimotor Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the effects of two types of electrical nerve stimulation techniques-Transcutaneous Electrical Nerve Stimulation (TENS) and Percutaneous Electrical Nerve Stimulation (PENS)-on the sensory and motor components of the radial nerve in healthy volunteers. Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive, low-cost, and widely used electrotherapy technique that applies electrical currents through surface electrodes on the skin to relieve pain. Percutaneous Electrical Nerve Stimulation (PENS) is a minimally invasive technique that delivers the electrical current through fine needles inserted near a peripheral nerve, potentially producing stronger physiological effects. In this randomized, double-blind controlled clinical trial, 120 healthy participants aged 18-60 years will be randomly assigned to one of four groups: Transcutaneous Electrical Nerve Stimulation (TENS) Percutaneous Electrical Nerve Stimulation (PENS) Sham Transcutaneous Electrical Nerve Stimulation (TENS) (placebo) Sham Percutaneous Electrical Nerve Stimulation (placebo) Each participant will receive one 20-minute stimulation session. Outcomes will include: Pressure pain threshold (PPT) (measured with an algometer), Thermal pain threshold (measured with a thermode), Maximal Isometric wrist extensor strength (measured with a hand-held dynamometer). The goal is to determine whether Percutaneous Electrical Nerve Stimulation (PENS) produces greater changes in sensory and motor parameters than Transcutaneous Electrical Nerve Stimulation (TENS) and to evaluate differences compared to placebo. This research will improve understanding of the physiological effects of these commonly used electrotherapy modalities and support evidence-based decision-making in clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcutaneous Electrical Nerve Stimulation (TENS)

Trials testing the same drug.

Other University of Castilla-La Mancha trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07247721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing